Show simple item record

dc.contributor.authorWitherington, Jason
dc.contributor.authorBordas, Vincent
dc.contributor.authorCooper, Dave G.
dc.contributor.authorForbes, Ian T.
dc.contributor.authorGribble, Andrew D.
dc.contributor.authorIfe, Robert J.
dc.contributor.authorBerkhout, Theo
dc.contributor.authorGohil, Jayneeta
dc.contributor.authorGroot, Pieter H. E.
dc.identifier.citationWitherington , J , Bordas , V , Cooper , D G , Forbes , I T , Gribble , A D , Ife , R J , Berkhout , T , Gohil , J & Groot , P H E 2001 , ' Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists ' , Bioorganic and Medicinal Chemistry Letters , vol. 11 , no. 16 , pp. 2177-2180 .
dc.identifier.otherPURE: 7129500
dc.identifier.otherPURE UUID: 8f602834-7de8-45e3-9f33-57ec71f20ec0
dc.identifier.otherScopus: 0035921020
dc.identifier.otherPubMed: 11514164
dc.description.abstractThe preparation and biological evaluation of a series of indolopiperidine CCR2B receptor antagonists possessing a conformationally restricted C-5 linker chain in combination with a restricted piperidine ring are described. Compared to the parent compound 1, analogue 8 shows a dramatic improvement in selectivity against a range of 5-HT and dopaminergic receptors.en
dc.relation.ispartofBioorganic and Medicinal Chemistry Letters
dc.subjectMolecular Biology
dc.subjectOrganic Chemistry
dc.subjectDrug Discovery
dc.subjectPharmaceutical Science
dc.titleConformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionMedicinal and Analytical Chemistry
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record